Cargando…
Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy
Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Research Network of Computational and Structural Biotechnology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173364/ https://www.ncbi.nlm.nih.gov/pubmed/37181656 http://dx.doi.org/10.1016/j.csbj.2023.04.016 |
_version_ | 1785039803785412608 |
---|---|
author | Ning, Yumei Lin, Kun Fang, Jun Ding, Yang Zhang, Zhang Chen, Xiaojia Zhao, Qiu Wang, Haizhou Wang, Fan |
author_facet | Ning, Yumei Lin, Kun Fang, Jun Ding, Yang Zhang, Zhang Chen, Xiaojia Zhao, Qiu Wang, Haizhou Wang, Fan |
author_sort | Ning, Yumei |
collection | PubMed |
description | Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein, we conducted a comprehensive pan-cancer analysis of MS subtypes across seven GI-cancer types. Using unsupervised clustering based on literature-derived MS-specific pathway signatures, the GI-tumor samples were divided into three MS subtypes, termed as the Soft, Mixed and Stiff. Then, distinct prognoses, biological features, tumor microenvironments and mutation landscapes among three MS subtypes were revealed. The Stiff tumor subtype was associated with the poorest prognosis, the most malignant biological behaviors, and the immunosuppressive tumor stromal microenvironment. Furthermore, multiple machine learning algorithms were used to develop an 11-gene MS-signature to identify the MS subtypes of GI-caner and predict chemotherapy sensitivity, which were further validated in two external GI-cancer cohorts. This novel MS-based classification on GI-cancers could enhance our understanding of the important role of MS in tumor progression, and may have implications for the optimization of individualized cancer management. |
format | Online Article Text |
id | pubmed-10173364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Research Network of Computational and Structural Biotechnology |
record_format | MEDLINE/PubMed |
spelling | pubmed-101733642023-05-12 Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy Ning, Yumei Lin, Kun Fang, Jun Ding, Yang Zhang, Zhang Chen, Xiaojia Zhao, Qiu Wang, Haizhou Wang, Fan Comput Struct Biotechnol J Research Article Gastrointestinal (GI) cancers are a heterogeneous group of primary solid tumors, arising in GI tract from the esophagus to rectum. Matrix stiffness (MS) is a critical physical factor for cancer progression; however, its importance in tumor progression remains to be comprehensively recognized. Herein, we conducted a comprehensive pan-cancer analysis of MS subtypes across seven GI-cancer types. Using unsupervised clustering based on literature-derived MS-specific pathway signatures, the GI-tumor samples were divided into three MS subtypes, termed as the Soft, Mixed and Stiff. Then, distinct prognoses, biological features, tumor microenvironments and mutation landscapes among three MS subtypes were revealed. The Stiff tumor subtype was associated with the poorest prognosis, the most malignant biological behaviors, and the immunosuppressive tumor stromal microenvironment. Furthermore, multiple machine learning algorithms were used to develop an 11-gene MS-signature to identify the MS subtypes of GI-caner and predict chemotherapy sensitivity, which were further validated in two external GI-cancer cohorts. This novel MS-based classification on GI-cancers could enhance our understanding of the important role of MS in tumor progression, and may have implications for the optimization of individualized cancer management. Research Network of Computational and Structural Biotechnology 2023-04-20 /pmc/articles/PMC10173364/ /pubmed/37181656 http://dx.doi.org/10.1016/j.csbj.2023.04.016 Text en © 2023 The Authors. Published by Elsevier B.V. on behalf of Research Network of Computational and Structural Biotechnology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Ning, Yumei Lin, Kun Fang, Jun Ding, Yang Zhang, Zhang Chen, Xiaojia Zhao, Qiu Wang, Haizhou Wang, Fan Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title | Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title_full | Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title_fullStr | Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title_full_unstemmed | Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title_short | Gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
title_sort | gastrointestinal pan-cancer landscape of tumor matrix heterogeneity identifies biologically distinct matrix stiffness subtypes predicting prognosis and chemotherapy efficacy |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173364/ https://www.ncbi.nlm.nih.gov/pubmed/37181656 http://dx.doi.org/10.1016/j.csbj.2023.04.016 |
work_keys_str_mv | AT ningyumei gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT linkun gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT fangjun gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT dingyang gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT zhangzhang gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT chenxiaojia gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT zhaoqiu gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT wanghaizhou gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy AT wangfan gastrointestinalpancancerlandscapeoftumormatrixheterogeneityidentifiesbiologicallydistinctmatrixstiffnesssubtypespredictingprognosisandchemotherapyefficacy |